LDAC Technology

The preferential nature of LDAC technology results from the increased susceptibility – as compared to healthy tissue — of certain cancer cell types to low intensity, low voltage electric fields.  The result is a cancer treatment technology that has demonstrated an ability to destroy tumors while leaving nerves, blood vessels and other tissue types within the field of treatment intact.  The clinical advantages of this technology have the potential to create a dramatic shift in the established cancer treatment paradigm.  Click here to read about the recent prostate cancer xenograft study at the University of Washington, Seattle WA that details the tumor killing ability of LDAC – published in the medical journal The Prostate.